GCP
CDAK

GSA Capital Partners’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

GSA Capital Partners’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-101,279
Closed -$635K – 1939
2022
Q1 		$635K Buy
+101,279
New +$635K 0.09% 390